Incyte to Report First Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street wavers as Federal Reserve holds key rate steady, pending more data
- SK Hynix shares surge after Q3 profit beats expectations
- Oil prices rise on Yemen fighting, Saudi refinery attack
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
| Incyte Genomics, Inc. (NASDAQ: INCY) | Delayed: 117.33 +0.73 (0.63%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $116.60 | 52 Week High | $118.49 | |||
| Open | $115.50 | 52 Week Low | $55.00 | |||
| Day High | $118.49 | P/E | N/A | |||
| Day Low | $114.74 | EPS | $-0.56 | |||
| Volume | 831,937 | |||||
